Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of recombinant human Neuregulin-1 in chronic diastolic heart failure
ChiCTR-TRC-09000416Phase 2Suspended
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jul 2007
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of neucardin in heart failure with preserved ejection fraction (HFpEF) and chronic heart failure (CHF) (4 arms), sponsored by Chinese Academy of Medical Sciences. Primary endpoint: Left ventricular systolic and diastolic function improvement. Started Jul 2007; status: suspended.
02
Drugs
neucardin
03
Conditions
heart failure with preserved ejection fraction (HFpEF)chronic heart failure (CHF)
Beyond the preview
Go deeper on ChiCTR-TRC-09000416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000416.